On May 28, Thermo Fisher Scientific rose 3.13% in regular trading, trading at $471.28/share, with trading volume of $122 million.
On the news front, OpenAI recently launched GPT-Rosalind, a new AI model dedicated to life sciences research, and has entered into a collaboration with Thermo Fisher Scientific to integrate the model into various workflows. The AI-empowered life sciences theme continues to gain momentum in the market. GPT-Rosalind is also being deployed with partners including Amgen, Moderna, and the Allen Institute, signaling broad industry adoption of AI-driven research tools.
Meanwhile, the Life Sciences Tools & Services sector rallied broadly, amplifying the upward momentum. Among sector peers, Agilent surged 13.99%, Icon PLC gained 7.24%, Tempus AI rose 3.76%, Danaher climbed 2.77%, and Revvity added 1.83%, reflecting a pronounced sector linkage effect that further supported Thermo Fisher's advance.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)